Response Assessment to Pembrolizumab With Standard of Care Therapy in Oligometastatic Brain Tumors From Melanoma, and Glioblastoma Using Ferumoxytol Steady State Imaging? A Pilot Study
Phase of Trial: Phase II
Latest Information Update: 28 Dec 2017
At a glance
- Drugs Ferumoxytol (Primary) ; Pembrolizumab
- Indications Brain cancer
- Focus Diagnostic use
- 31 Aug 2018 Biomarkers information updated
- 20 Dec 2017 Status changed from not yet recruiting to recruiting.
- 14 Dec 2017 Planned initiation date changed from 30 Nov 2017 to 20 Dec 2017.